LG AI Research on Wednesday revealed Exaone Path 2.0, its upgraded artificial intelligence (AI) model designed to advance cancer diagnosis and drug development.
Foreigners in Korea face medical access issues due to staffing shortages and language barriers, leading to delays and inadequate care, especially in urgent situations.
The Korean government will move forward with its health care reform initiatives, including a 280 billion won ($191 million) investment this year to improve the training environment for medical residents.
The U.S. Embassy in Seoul issued a public alert warning that access to health care in Korea may be significantly disrupted due to an ongoing shortage of physicians.
A total of 467 medical professors resigned even before reaching their retirement age last year, accounting for nearly 75 percent of all medical professors who resigned nationwide.
Of the 269 doctors who obtained their medical license in January, 52, or 19.3 percent, held medical degrees from foreign institutions.
The Ministry of Health and Welfare on Thursday announced that some 16,815 medical clinics and hospitals will remain open across the country daily during the Lunar New Year holiday season starting Saturday.
Samsung Biologics has secured a record $1.41 billion contract with an unnamed European pharmaceutical company, the contract development and manufacturing organization (CDMO) announced in an electronic disclosure Tuesday.
Korean biopharmaceutical firms Samsung Biologics, Celltrion, and Lotte Biologics will showcase their advancements at the J.P. Morgan Healthcare Conference.
Lotte is closing down its digital health care business, a sector it had once deemed a future growth engine, as it shutters down unprofitable projects amid continued speculation of a potential liquidity crisis at the group.
Korea JoongAng Daily Sitemap
